CME and NYSE lobby CFTC against Hyperliquid amid USDC liquidity risks
Two of the largest traditional exchanges in the world are asking US regulators to put a leash on a decentralized platform that didnt exist a few years ago. CME Group and Intercontinental Exchange, which operates the New York Stock Exchange, are lobbying the Commodity Futures Trading Commission to impose tighter regulations on Hyperliquid, the on-chain perpetual futures exchange that currently dominates decentralized derivatives trading. Their stated concerns include potential market manipulation, sanctions evasion, and the risk of undermining traditional commodity price discovery, particularly in oil markets. The platform they want to rein in Hyperliquid commands roughly 53% of fees in the on-chain derivatives sector, with over $2.45 billion in open interest. It‘s processing more perpetual futures volume than every other decentralized competitor combined, and it’s doing so without a traditional exchange license. The HYPE token dropped between 9% and 14% following reports of the lobbying effort. The USDC dependency problem Hyperliquid‘s market infrastructure is built around Circle’s stablecoin. Through integrations with both Coinbase and Circle, USDC serves as the foundational collateral asset for trading on the platform. If the CFTC or other regulators lean on Circle to restrict USDC flows to Hyperliquid, the platforms liquidity could evaporate without regulators ever having to touch the protocol itself. Circle